Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioFactors is a Polish pharmaceutical company specializing in the production of high-quality active pharmaceutical ingredients (APIs) of biological origin. The company is primarily recognized for its expertise in the manufacturing of heparin and low-molecular-weight heparins (LMWHs) such as enoxaparin and nadroparin. BioFactors operates state-of-the-art manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards. Their products are utilized globally in the treatment and prevention of thromboembolic disorders. In addition to its core manufacturing capabilities, the company engages in the development of purified biological substances for the pharmaceutical industry. BioFactors serves as a key partner for pharmaceutical companies requiring reliable supplies of complex biological anticoagulants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biofactors.